ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1023

Scoring Radiographic Progression in Axial Spa: Should We Use the Modified Stoke in Ankylosing Spondylitis Spine Score or the Radiographic Ankylosing Spondylitis Spinal Score?

Sofia Ramiro1, A.M. Van Tubergen2, Carmen Stolwijk3, Robert Landewé4 and Désirée van der Heijde5, 1Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam, The Netherlands and Hospital Garcia de Orta, Almada, Portugal, 2Department of Medicine, Maastricht University Medical Center, Maastricht, Netherlands, 3Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 4Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Heerlen, Netherlands, 5Rheumatology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: imaging techniques, Outcome measures and spondylarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases: Magnetic Resonance Imaging, Computed Tomography and X-ray

Session Type: Abstract Submissions (ACR)

Background/Purpose: Radiographic damage is one of the core outcomes in axial SpA and it is usually assessed with the modified Stoke Ankylosing Spondylitis (AS) Spine Score (mSASSS). The recently proposed Radiographic AS Spinal Score (RASSS)[1] includes an assessment of the lower thoracic vertebrae, under the hypothesis that most progression occurred in these segments. We aimed to compare the mSASSS and RASSS with regard to efficiency and added value.

Methods: Two-yearly spinal radiographs from patients followed in the Outcome in AS International Study (OASIS) were used. Two readers independently scored the x-rays, and averaged scores per vertebral corner (VC) were used. Only radiographs with ≤3 missing VCs per segment (cervical and lumbar, the latter with 4 thoracic VCs included as described for the RASSS) were included, so that both scores could be calculated. Status- and 2-year progression scores of both scoring methods were compared, first in terms of their availability. To assess the potential additional value of including the thoracic segment in the score, the relative contribution (in %) to the 2-year total RASSS progression of each spinal segment (cervical, thoracic and lumbar) was determined, and compared to the expected contribution, assuming a balanced segmental progression and proportional to the number of sites (12 cervical VCs, 4 thoracic VCs and 12 lumbar VCs).

Results: The mSASSS could be scored in a total of 809 radiographs. The RASSS could be calculated in 78% of these radiographs. In 58% of those, the RASSS was calculated based on 1 or 2 present thoracic VC scores (of the 4 possible thoracic VC scores), and the remaining 2-3 had to be imputed because they were missing (these imputed VCs were therefore uninformative). There were 520 two-year mSASSS interval progression scores available, and in 63% of them a 2-year RASSS interval progression score could be determined.  

Of all the radiographs in which both scores could be determined (n=629), the mean (SD) status- score was 15.5 (17.9) units for the mSASSS and 18.0 (20.9) units for the RASSS. The mean (SD) 2-year interval progression scores (in 330 two-year intervals) were 2.0 (3.6) for the mSASSS and 2.4 (4.4) for the RASSS. Exclusive progression of the thoracic segment occurred in only 5% of the cases. There were no significant differences between the observed and expected contributions of the thoracic segment to progression (Table), whilst progression was more frequently than expected observed in the cervical spine, and less frequently in the lumbar spine.

Conclusion: The determination of a RASSS for status or progression of radiographic abnormalities in the spine is frequently impossible or strongly influenced by non-contributory imputation. In comparison to the conventional mSASSS method, the contribution of thoracic VCs in the RASSS-method is negligible, and does not justify the additional scoring efforts.  

References:A&R:61,764-71

Table – Ratio of 2-year progression in each of the spinal segments of the RASSS

 

Relative contribution to total RASSS progression (in %)

 

 

Expected

Observed

P-value for the difference

Cervical segment (12 VCs)

43

55

0.09

Lumbar segment (12 VCs)

43

29

0.04

Thoracic segment (4 VCs)

14

16

0.70

Total (28 VCs)

100

100

 


Disclosure:

S. Ramiro,
None;

A. M. Van Tubergen,
None;

C. Stolwijk,
None;

R. Landewé,
None;

D. van der Heijde,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/scoring-radiographic-progression-in-axial-spa-should-we-use-the-modified-stoke-in-ankylosing-spondylitis-spine-score-or-the-radiographic-ankylosing-spondylitis-spinal-score/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology